Viewing Study NCT03824795


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-01-01 @ 12:33 AM
Study NCT ID: NCT03824795
Status: COMPLETED
Last Update Posted: 2020-04-15
First Post: 2019-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD
Sponsor: MGB Biopharma Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module